Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019Emma Nichols, Vera Marisa Costa, Jaimie D Steinmetz et al.|The Lancet Public Health|2022Cited by 5.1k
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Alize J Ferrari, Robert Kaba Alhassan et al.|The Lancet|2024Cited by 4.4k
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease StudyRupert Bourne, Joshua R. Ehrlich, Pankaj Bhardwaj et al.|The Lancet Global Health|2020Cited by 1.3k
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021Azalea Thomson, Deepa Dongarwar, Theresa A. McHugh et al.|The Lancet Haematology|2023Cited by 674
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017Farin Kamangar, Pawan Faris, Dariush Nasrollahzadeh et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 643